UNI-EN 9:NOTIFICATION OF INSIDER’S TRANSACTIONS
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 9 | / | 2011 | | ||||||
| Date of issue: | 2011-12-05 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| NOTIFICATION OF INSIDER’S TRANSACTIONS | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osób mających dostęp do informacji poufnych | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of SOPHARMA AD (the “Company") announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that the company Elpharma AD, a person closely associated with him, executed the following transactions with shares in the Company: • on 1 December 2011, Elpharma AD disposed of 700 shares for the price of BGN 3.18 each; • on 1 December 2011, Elpharma AD disposed of 10 shares for the price of BGN 3.22 each; • on 1 December 2011, Elpharma AD disposed of 523 shares for the price of BGN 3.22 each; • on 1 December 2011, Elpharma AD disposed of 300 shares for the price of BGN 3.22 each; • on 1 December 2011, Elpharma AD disposed of 167 shares for the price of BGN 3.22 each; • on 2 December 2011, Elpharma AD disposed of 500 shares for the price of BGN 3.235 each. The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) during the ordinary exchange sessions. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | nd | ||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2011-12-05 | Ognian Donev | Chairman of the Board of Directors | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
